Weinhäuser et al. found that the poor OS prediction associated with high CD163/CD206 mRNA expression is not necessarily driven by intrinsic AML biology but could be attributed to the presence of an AML tumor supportive niche39,52,53. This evidence concerns the gene MRC1 and acute myeloid leukemia.